002872 ST天聖製藥
按盤價 
4.340 +0.080 (+1.878%)
4.340 +0.080 (+1.878%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 402,357 | -0.99% | 579,335 | 606,992 | 736,686 | 1,202,746 | |
| 減：營業總成本 | 461,244 | -7.94% | 675,593 | 712,465 | 813,592 | 1,372,965 | |
| 其中:營業成本 | 221,602 | -0.56% | 306,568 | 263,594 | 432,703 | 852,832 | |
| 財務費用 | 6,115 | 11.27% | 6,685 | 8,275 | 8,994 | 32,990 | |
| 資產減值損失 | (4,234) | 69.33% | (15,735) | (15,705) | (10,468) | (371,137) | |
| 公允價值變動收益 | 816 | 189.36% | 330 | (192) | (390) | (1,320) | |
| 投資收益 | 16,168 | -82,996.89% | 1,681 | 5,113 | 4,960 | (1,253) | |
| 其中：對聯營企業和合營企業的投資收益 | (3,548) | 333.24% | 1,318 | 2,843 | (16,628) | -- | |
| 營業利潤 | (38,695) | -54.03% | (93,573) | (84,706) | (60,992) | (500,343) | |
| 利潤總額 | (38,893) | -55.95% | (94,723) | (84,116) | (54,444) | (534,578) | |
| 減：所得稅費用 | (1,813) | -70.33% | (1,011) | 7,437 | 17,895 | (40,993) | |
| 淨利潤 | (37,081) | -54.89% | (93,713) | (91,553) | (72,339) | (493,585) | |
| 減：非控股權益 | (729) | 97.27% | (639) | (990) | (4,534) | (2,853) | |
| 股東淨利潤 | (36,352) | -55.57% | (93,074) | (90,563) | (67,805) | (490,732) | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.114 | -55.58% | -0.293 | -0.285 | -0.213 | -1.543 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 6.467 | -2.14% | 6.577 | 6.864 | 7.149 | 7.360 | |
| 審計意見 # | -- | 保留意见 | 保留意见 | 保留意见 | 保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 04/11/2024 14:49 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
